Alterations in SLC4A2, SLC26A7 and SLC26A9 Drive Acid–Base Imbalance in Gastric Neuroendocrine Tumors and Uncover a Novel Mechanism for a Co-Occurring Polyautoimmune Scenario. This evidence concerns the gene SLC26A7 and gastric neuroendocrine tumor, well differentiated, low or intermediate grade.